Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (16129)
All Articles published online
|
Publishing Process of This Article
|
Jul 26, 2015 (publication date) through Jan 11, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | DuBroff R, de Lorgeril M. Cholesterol confusion and statin controversy. World J Cardiol 2015; 7(7): 404-409 [PMID: 26225201 DOI: 10.4330/wjc.v7.i7.404] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v7/i7/404.htm |
| Number | Citing Articles |
| 1 |
Yang Wang, Jinsong Wang, Shenming Wang. Comparative Effectiveness of Inclisiran 100, 300, and 500 mg in a Population with Hyperlipidemia: A Network Meta-Analysis of Randomized Controlled Trials. American Journal of Cardiovascular Drugs 2018; 18(4): 271 doi: 10.1007/s40256-018-0270-7
|
| 2 |
Nikolaos Tzenios, Erin D. Lewis, David C. Crowley, Mohamad Chahine, Malkanthi Evans. Examining the Efficacy of a Very-Low-Carbohydrate Ketogenic Diet on Cardiovascular Health in Adults with Mildly Elevated Low-Density Lipoprotein Cholesterol in an Open-Label Pilot Study. Metabolic Syndrome and Related Disorders 2022; 20(2): 94 doi: 10.1089/met.2021.0042
|
| 3 |
Onkar Bedi, Veena Dhawan, P. L. Sharma, Puneet Kumar. Pleiotropic effects of statins: new therapeutic targets in drug design. Naunyn-Schmiedeberg's Archives of Pharmacology 2016; 389(7): 695 doi: 10.1007/s00210-016-1252-4
|
| 4 |
Shun Tanimura, Mutsumi Nishida, Tatsunori Horie, Tamotsu Kamishima, Hitomi Matsumoto, Yutaka Morimura, Yuka Nishibata, Sakiko Masuda, Daigo Nakazawa, Utano Tomaru, Tatsuya Atsumi, Akihiro Ishizu. Fluvastatin prevents the development of arthritis in env-pX rats via up-regulation of Rho GTPase-activating protein 12. Experimental and Molecular Pathology 2020; 115: 104454 doi: 10.1016/j.yexmp.2020.104454
|
| 5 |
Monika Kopec, Karolina Beton-Mysur, Halina Abramczyk. Raman imaging and chemometric methods in human normal bronchial and cancer lung cells: Raman biomarkers of lipid reprogramming. Chemistry and Physics of Lipids 2023; 257: 105339 doi: 10.1016/j.chemphyslip.2023.105339
|
| 6 |
Dong-Hyeon Lee, Ho-Joong Youn, Hae-Ok Jung, Kiyuk Chang, Yun-Seok Choi, Jung Im Jung. Coronary artery calcium score plays an important role for cardiovascular risk stratification in the statin benefit groups of asymptomatic individuals. Lipids in Health and Disease 2017; 16(1) doi: 10.1186/s12944-017-0560-0
|
| 7 |
Liang Gu, Sourav Taru Saha, Jodie Thomas, Mandeep Kaur. Targeting cellular cholesterol for anticancer therapy. The FEBS Journal 2019; 286(21): 4192 doi: 10.1111/febs.15018
|
| 8 |
Daniel A. Hofmaenner, Anna Kleyman, Adrian Press, Michael Bauer, Mervyn Singer. The Many Roles of Cholesterol in Sepsis: A Review. American Journal of Respiratory and Critical Care Medicine 2022; 205(4): 388 doi: 10.1164/rccm.202105-1197TR
|
| 9 |
Alexander N Kharlamov. Why do we fail to achieve Glagovian atheroregression in lipid-lowering trials?. Interventional Cardiology 2015; 7(5): 469 doi: 10.2217/ica.15.37
|
| 10 |
Axel Haverich, Erin Colleen Boyle. Atherosclerosis Pathogenesis and Microvascular Dysfunction. 2019; : 9 doi: 10.1007/978-3-030-20245-3_2
|
| 11 |
Afshin Amirpoor, Reihaneh Zavar, Atefeh Amerizadeh, Sedigheh Asgary, Sajjad Moradi, Mohammad Hosein Farzaei, Gholamreza Masoumi, Masoumeh Sadeghi. Effect of Beetroot Consumption on Serum Lipid Profile: A Systematic Review and Meta-Analysis. Current Problems in Cardiology 2022; 47(7): 100887 doi: 10.1016/j.cpcardiol.2021.100887
|
| 12 |
David M. Diamond, Michel de Lorgeril, Malcolm Kendrick, Uffe Ravnskov, Paul J. Rosch, Hajo Zeeb. Formal comment on “Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease”. PLOS ONE 2019; 14(1): e0205138 doi: 10.1371/journal.pone.0205138
|
| 13 |
Azhar Hussain, Jasndeep Kaler, Sidhartha D Ray. The Benefits Outweigh the Risks of Treating Hypercholesterolemia: The Statin Dilemma. Cureus 2023; doi: 10.7759/cureus.33648
|
| 14 |
Alexander N. Kharlamov. Scaffold thrombosis: Exaggerated illusion, or when statistics rules. International Journal of Cardiology 2016; 209: 206 doi: 10.1016/j.ijcard.2016.02.054
|
| 15 |
D. M. Aronov, M. G. Bubnova, O. M. Drapkina. Atherosclerosis pathogenesis from the perspective of microvascular dysfunction. Cardiovascular Therapy and Prevention 2021; 20(7): 3076 doi: 10.15829/1728-8800-2021-3076
|
| 16 |
Rosa Vona, Elisabetta Iessi, Paola Matarrese. Role of Cholesterol and Lipid Rafts in Cancer Signaling: A Promising Therapeutic Opportunity?. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.622908
|
| 17 |
Maryanne Demasi. Statin wars: have we been misled about the evidence? A narrative review. British Journal of Sports Medicine 2018; 52(14): 905 doi: 10.1136/bjsports-2017-098497
|
| 18 |
Zhenqi Liu, Baichun Yang. Drug Development Strategy for Type 2 Diabetes: Targeting Positive Energy Balances. Current Drug Targets 2019; 20(8): 879 doi: 10.2174/1389450120666181217111500
|
| 19 |
Sherif Sultan, Ashwini D'Souza, Ioannis Zabetakis, Ronan Lordan, Alexandros Tsoupras, Edel P. Kavanagh, Niamh Hynes. The Impact of Nutrition and Statins on Cardiovascular Diseases. 2019; : 171 doi: 10.1016/B978-0-12-813792-5.00006-9
|
| 20 |
Zsolt Murlasits. A call for the better utilization of physical activity and exercise training in the defense against cardiovascular disease. The Physician and Sportsmedicine 2015; 43(4): 329 doi: 10.1080/00913847.2015.1095618
|
| 21 |
Mohamed A. Jalloh, Eric J. Ip, Shadi Doroudgar. What is the impact of the 2017 cochrane systematic review and meta-analysis that evaluated the use of PCSK9 inhibitors for lowering cardiovascular disease and mortality?. Expert Opinion on Pharmacotherapy 2018; 19(7): 739 doi: 10.1080/14656566.2018.1464558
|
| 22 |
Annette Leibing. Situated Prevention: Framing the “New Dementia”. Journal of Law, Medicine & Ethics 2018; 46(3): 704 doi: 10.1177/1073110518804232
|
| 23 |
Elżbieta Paszek, Wojciech Zajdel, Tomasz Rajs, Krzysztof Żmudka, Jacek Legutko, Paweł Kleczyński. Profilin 1 and Mitochondria—Partners in the Pathogenesis of Coronary Artery Disease?. International Journal of Molecular Sciences 2021; 22(3): 1100 doi: 10.3390/ijms22031100
|
| 24 |
Kun Huang, Hanjoong Jo, Jing Echesabal-Chen, Alexis Stamatikos. Combined LXR and RXR Agonist Therapy Increases ABCA1 Protein Expression and Enhances ApoAI-Mediated Cholesterol Efflux in Cultured Endothelial Cells. Metabolites 2021; 11(9): 640 doi: 10.3390/metabo11090640
|
| 25 |
Axel Haverich, Erin Colleen Boyle. Atherosklerose-Pathogenese und mikrovaskuläre Dysfunktion. 2023; : 9 doi: 10.1007/978-3-031-31766-8_2
|
| 26 |
Qian Xu, Yiming Deng, Jun Xiao, Xiangrui Liu, Min Zhou, Zhong Ren, Juan Peng, Yaling Tang, Zhisheng Jiang, Zhihan Tang, Lushan Liu. Three Musketeers for Lowering Cholesterol: Statins, Ezetimibe and Evolocumab. Current Medicinal Chemistry 2021; 28(5): 1025 doi: 10.2174/0929867327666200505091738
|
| 27 |
Dawn M. Fernandez, Jose C. Clemente, Chiara Giannarelli. Physical Activity, Immune System, and the Microbiome in Cardiovascular Disease. Frontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.00763
|
| 28 |
Rumi Iqbal Doewes, Ghazal Gharibian, Firoozeh Abolhasani zadeh, Burhan Abdullah Zaman, Sahar vahdat, Reza Akhavan-Sigari. An Updated Systematic Review on the Effects of Aerobic Exercise on Human Blood Lipid Profile. Current Problems in Cardiology 2023; 48(5): 101108 doi: 10.1016/j.cpcardiol.2022.101108
|
| 29 |
Hayrettin Ozan Gulcan, Serkan Yigitkan, Ilkay Erdogan Orhan. The Natural Products as Hydroxymethylglutaryl-Coa Reductase Inhibitors. Letters in Drug Design & Discovery 2019; 16(10): 1130 doi: 10.2174/1570180816666181112144353
|
| 30 |
Stefan Dragulinescu. Inference to the best explanation and mechanisms in medicine. Theoretical Medicine and Bioethics 2016; 37(3): 211 doi: 10.1007/s11017-016-9365-9
|
| 31 |
Justin Tondt, William S. Yancy, Eric C. Westman. Application of nutrient essentiality criteria to dietary carbohydrates. Nutrition Research Reviews 2020; 33(2): 260 doi: 10.1017/S0954422420000050
|
| 32 |
Mazaher Ahmadi, Shayan Amiri, Stevan Pecic, Filip Machaj, Jakub Rosik, Marek J. Łos, Javad Alizadeh, Reza Mahdian, Simone C. da Silva Rosa, Dedmer Schaafsma, Shahla Shojaei, Tayyebeh Madrakian, Amir A. Zeki, Saeid Ghavami. Pleiotropic effects of statins: A focus on cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020; 1866(12): 165968 doi: 10.1016/j.bbadis.2020.165968
|
| 33 |
Etienne Ho Kit Mok, Terence Kin Wah Lee. The Pivotal Role of the Dysregulation of Cholesterol Homeostasis in Cancer: Implications for Therapeutic Targets. Cancers 2020; 12(6): 1410 doi: 10.3390/cancers12061410
|
| 34 |
Shiyong Yu, Jun Jin, Zhongxiu Chen, Xiaolu Luo. High-intensity statin therapy yields better outcomes in acute coronary syndrome patients: a meta-analysis involving 26,497 patients. Lipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01369-6
|
| 35 |
Malkanthi Evans, Erin D. Lewis, Joseph M. Antony, David C. Crowley, Andrew Charrette, Najla Guthrie, Jeffrey B. Blumberg, Gregor Reid. Revisiting the Definition of ‘Healthy’ Participants in Substantiation of Structure/Function Claims for Dietary Supplements. Journal of Dietary Supplements 2025; 22(1): 41 doi: 10.1080/19390211.2023.2301383
|
| 36 |
Jacques Blacher. L’hypertension artérielle en France, une situation préoccupante : une réplique du tremblement de terre cholestérol/statines ?. La Presse Médicale 2018; 47(6): 497 doi: 10.1016/j.lpm.2018.05.011
|
| 37 |
Xin Guo, Mingming Gao, Yunan Wang, Xiao Lin, Liu Yang, Nathan Cong, Xiangbo An, Feng Wang, Kai Qu, Liqing Yu, Yuhui Wang, Jinjie Wang, Haibo Zhu, Xunde Xian, George Liu. LDL Receptor Gene-ablated Hamsters: A Rodent Model of Familial Hypercholesterolemia With Dominant Inheritance and Diet-induced Coronary Atherosclerosis. EBioMedicine 2018; 27: 214 doi: 10.1016/j.ebiom.2017.12.013
|
| 38 |
Harold Edward Bays.
Alirocumab, Decreased Mortality, Nominal Significance,
P
Values, Bayesian Statistics, and the Duplicity of Multiplicity
. Circulation 2019; 140(2): 113 doi: 10.1161/CIRCULATIONAHA.119.041496
|
| 39 |
Aleyda Benitez‐Amaro, Chiara Pallara, Laura Nasarre, Ruben Ferreira, David de Gonzalo‐Calvo, Roger Prades, Teresa Tarragó, Vicenta Llorente‐Cortés. Development of Innovative Antiatherosclerotic Peptides through the Combination of Molecular Modeling and a Dual (Biochemical‐Cellular) Screening System. Advanced Therapeutics 2020; 3(8) doi: 10.1002/adtp.202000037
|
| 40 |
Carlo Martini, Mattia Andreoletti. Genuine versus bogus scientific controversies: the case of statins. History and Philosophy of the Life Sciences 2021; 43(4) doi: 10.1007/s40656-021-00456-w
|
| 41 |
A. P. Vasiliev, N. N. Streltsova. Contradictions in traditional ideas about atherosclerosis and the efficacy of lipid-lowering therapy. Promising directions. Сибирский научный медицинский журнал 2024; 44(4): 38 doi: 10.18699/SSMJ20240404
|
| 42 |
T. Vidal-Trécan, M. Laloi-Michelin, C. Bouché, V. Juddoo, J.-G. Dillinger, I. Azancot, J.-P. Kevorkian, L. Salle, F. Feron, P. Henry, J.F. Gautier, J.-. Riveline. Can the ESC/EAS LDL-cholesterol target in patients with diabetes and high cardiovascular risk be achieved in clinical practice? Results from an ambulatory multidisciplinary diabetes center cohort. Diabetes & Metabolism 2019; 45(6): 592 doi: 10.1016/j.diabet.2018.01.010
|
| 43 |
Kobra Bahrampour Juybari, Azam Hosseinzadeh, Ali Mohammad Sharifi. Protective effects of atorvastatin against high glucose-induced nuclear factor-κB activation in cultured C28I2 chondrocytes. Journal of Receptors and Signal Transduction 2019; 39(1): 1 doi: 10.1080/10799893.2018.1557206
|
| 44 |
Arnoud van der Laarse, Christa M. Cobbaert. Biochemical risk factors of atherosclerotic cardiovascular disease: from a narrow and controversial approach to an integral approach and precision medicine. Expert Review of Cardiovascular Therapy 2021; 19(12): 1085 doi: 10.1080/14779072.2021.2022475
|
| 45 |
Marija Ljubičić, Marijana Matek Sarić, Ivo Klarin, Ivana Rumbak, Irena Colić Barić, Jasmina Ranilović, Ayman EL-Kenawy, Maria Papageorgiou, Elena Vittadini, Maša Černelič Bizjak, Raquel Guiné. Motivation for health behaviour: A predictor of adherence to balanced and healthy food across different coastal Mediterranean countries. Journal of Functional Foods 2022; 91: 105018 doi: 10.1016/j.jff.2022.105018
|
| 46 |
Chrystyne Olivieri. The current state of heart disease. International Journal of Evidence-Based Healthcare 2019; 17(3): 179 doi: 10.1097/XEB.0000000000000197
|
| 47 |
Waseem Hassan, Batool Ghorbani Yekta, Seyed Mohammad Nabavi, Maciej Banach, Aysa Rezabakhsh. The Progress and Research Trends of Statin Medications: Advanced Epidemiological and Bibliometrical Assessment. Current Problems in Cardiology 2023; 48(6): 101638 doi: 10.1016/j.cpcardiol.2023.101638
|